Catechol- O -methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria

Author： Lajin Bassam  

Publisher： Springer Publishing Company

ISSN： 1340-6868

Source： Breast Cancer, Vol.20, Iss.1, 2013-01, pp. : 62-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lack of association between catechol- O -methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls

By Mao Chen  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 719-725

Springer Publishing Company

Access to resources Recommend Favorite

Catechol- O -methyltransferase Val158Met polymorphism in breast cancer risk

By Xi Bo  

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 839-841

Springer Publishing Company

Access to resources Recommend Favorite

Catechol-O-methyltransferase Val158Met polymorphism and breast cancer risk in Asian population

By Li Kai   Li Wusheng   Zou Huawei  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2343-2350

Springer Publishing Company

Access to resources Recommend Favorite

COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case–control studies

By Ding Haixia   Fu Yuanyuan   Chen Weixian   Wang Zhanwei  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 265-270

Springer Publishing Company

Access to resources Recommend Favorite

HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies

By Lu Su  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 771-778

Springer Publishing Company

Access to resources Recommend Favorite